Literature DB >> 8040141

New anticancer drugs under clinical trials in Japan.

M Ogawa1, Y Ariyoshi.   

Abstract

A total of 16 drugs developed in Japan are currently under Phase I or II trials. This article reviews results of some studies of these drugs. Studies included in the article are of SM-5887, MX-2, DWA2114R, and CPT-11.

Mesh：

Substances：

Year:  1994        PMID： 8040141

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN： 0889-8588            Impact factor:   3.722


  1 in total

1.  Phase 1 Study of ABT-751 in Combination With CAPIRI (Capecitabine and Irinotecan) and Bevacizumab in Patients With Advanced Colorectal Cancer.

Authors:  Michelle A Rudek; Arvind Dasari; Daniel Laheru; Ping He; Runyan Jin; Rosalind Walker; Gretchen E Taylor; Antonio Jimeno; Ross C Donehower; Manuel Hidalgo; Wells A Messersmith; W Thomas Purcell
Journal:  J Clin Pharmacol       Date:  2016-02-02       Impact factor: 3.126
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.